AARTI PHARMALABS
|
The Current P/E Ratio of AARTI PHARMALABS is 28.14.
| Share Price | ₹752.3 | Dec 31,2025 |
| Market Cap | ₹6,815.8 Cr | |
| Earnings-TTM | ₹242.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.14x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AARTI PHARMALABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹6,815.8 Cr] as on Dec 31,2025
(/) Earnings [ ₹242.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.14x ]
Thus, for AARTI PHARMALABS , the investors are currently willing to pay 28.14 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AARTI PHARMALABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AARTI PHARMALABS over the last five years.
Historical PE (Price/Earnings) ratio chart of AARTI PHARMALABS
PE Ratio Performance Analysis for AARTI PHARMALABS
- AARTI PHARMALABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.19x.
- AARTI PHARMALABS 's operated at median p/e ratio of 12.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AARTI PHARMALABS 's p/e ratio peaked in Mar2025 at 24.91x.
- AARTI PHARMALABS 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does AARTI PHARMALABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AARTI PHARMALABS | 242.19 | 28.14 | 6,815.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.23 | 412,626.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.31 | 169,758.0 |
| CIPLA LTD | 5,453.86 | 22.38 | 122,046.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.76 | 130,021.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.54 | 106,086.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.31 | 90,666.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.51 | 92,035.2 |
| LUPIN LTD | 4,347.53 | 22.19 | 96,475.9 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.90 | 68,604.3 |
| ABBOTT INDIA LTD | 1,508.95 | 40.94 | 61,771.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AARTI PHARMALABS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.51x |
| Max industry PE | 68.31x |
| Median industry PE | 28.14x |
| Average industry PE | 35.47x |
You may also like the below Video Courses